Currently available literature indicates DSC3 expression by squamous NSCLC, ovarian cancer, cervical cancer, melanoma, colorectal cancer, meningioma, esophageal squamous cell carcinoma, sarcoma, and pediatric acute lymphoblastic leukemia (51, 52, 56–58, 185–188). Here, DSC3 is linked to melanoma.